We are live on ! Find out more
EW icon

Edwards Lifesciences

1,210 hedge funds and large institutions have $36.6B invested in Edwards Lifesciences in 2025 Q1 according to their latest regulatory filings, with 123 funds opening new positions, 387 increasing their positions, 489 reducing their positions, and 125 closing their positions.

New
Increased
Maintained
Reduced
Closed

45% more call options, than puts

Call options by funds: $257M | Put options by funds: $178M

1.04% more ownership

Funds ownership: 85.24% → 86.29% (+1%)

7% more capital inflows, than outflows

Capital inflows: $3B | Capital outflows: $2.82B

0% more funds holding in top 10

Funds holding in top 10: 10 → 10 (0)

2% less first-time investments, than exits

New positions opened: 123 | Existing positions closed: 125

2% less funds holding

Funds holding: 1,232 → 1,210 (-22)

21% less repeat investments, than reductions

Existing positions increased: 387 | Existing positions reduced: 489

Holders
1,210
Holders Change
-22
Holders Change %
-1.79%
% of All Funds
16.15%
Holding in Top 10
10
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.13%
New
123
Increased
387
Reduced
489
Closed
125
Calls
$257M
Puts
$178M
Net Calls
+$79.4M
Net Calls Change
-$247M

EW Hedge Fund Activity: Q1 2025 in Review

1,210 of the 7,491 institutional investors tracked by Wall St. Rank reported a position in Edwards Lifesciences (EW) for Q1 2025, worth a combined $36.6B — down 1.6% from $37.2B a quarter earlier.

Sellers outnumbered buyers: 125 funds closed out of EW and 123 opened new positions — a net loss of 2 holders — while 489 trimmed existing stakes and 387 added.

The largest buyer was JP Morgan Chase, adding an estimated $509M. The largest seller was Wellington Management Group, cutting an estimated $292M.

  • 1,210 institutional investors held Edwards Lifesciences (EW) as of Q1 2025, down from 1,232 in Q4 2024.
  • Funds reported $36.6B of Edwards Lifesciences stock for Q1 2025, down 1.6% quarter-over-quarter.
  • 123 funds opened new Edwards Lifesciences positions in Q1 2025 and 125 closed out, a net change of -2 holders.
  • The largest Edwards Lifesciences buyer in Q1 2025 was JP Morgan Chase, an estimated $509M added.
  • The largest Edwards Lifesciences seller in Q1 2025 was Wellington Management Group, an estimated $292M sold.

Based on aggregated 13F filings for Q1 2025.